Ketek

Defective Drug Lawyers: Ketek and Liver Failure

Ketek (telithromycin) is an antibiotic used to treat chronic respiratory infections, including sinusitis, bronchitis and pneumonia, that are resistant to other medications. It was approved by the FDA in 2004, even though the agency knew that some of the clinical trials involved in an important pre-approval study were fraudulent.

In January of 2006, the Annals of Internal Medicine reported that three people in a hospital in North Carolina developed jaundice and abnormal liver function after taking Ketek. One patient developed hepatitis, one required a kidney transplant and one died after taking the drug for only five days.

Passionate Representation, Historic Results
Contact Hersh & Hersh: 1-800-441-5545

An article defending the drug's effectiveness appeared in the New England Journal of Medicine, but it was later determined that all of the six authors had financial ties to the drug's manufacturer.

In June 2006, the FDA warned that just a few doses of Ketek could cause severe liver damage, liver failure or death. In February 2007, the FDA dropped approval of Ketek for treatment of bronchitis and sinusitis.

If you developed liver damage after taking the antibiotic Ketek, you have a right to pursue financial compensation for the damages you have suffered. Please contact an attorney at Hersh & Hersh to discuss your case. It costs you nothing to learn if you have a valid defective drug claim.

For more than 35 years, our attorneys have filed groundbreaking lawsuits in order to compensate victims and protect the public from dangerous and defective drugs.

From our offices in San Francisco, California, the lawyers of Hersh & Hersh represent clients injured by defective and dangerous drugs throughout the nation.